Lanean...
Biomarkers for the Early Detection and Progression of Alzheimer’s Disease
The recent failures of potential disease-modifying drugs for Alzheimer’s disease (AD) may reflect the fact that the enrolled participants in clinical trials are already too advanced to derive a clinical benefit. Thus, well-validated biomarkers for the early detection and accurate diagnosis of the pr...
Gorde:
| Argitaratua izan da: | Neurotherapeutics |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer US
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5233625/ https://ncbi.nlm.nih.gov/pubmed/27738903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-016-0481-z |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|